RAC 4.32% $1.55 race oncology ltd

Ann: RC220 Meets Quality Specifications, page-23

  1. 920 Posts.
    lightbulb Created with Sketch. 542
    Expect to be pleasantly surprised.
    Let's not forget the 1700 patients that have received Bisantrene in the past.
    How good was Bisantrene's efficacy in Sheba2 trial announced recently.
    RC220 progress in full swing.
    Advanced level discussions with partners ongoing.
    Make of what you will.



 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.